Clinical Trials Browser

Metastatic Non-Squamous Non-Small Cell Lung Cancer × pembrolizumab × 90 days × Clear all

NCT07098988 2026-05-13

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Phase 2 Recruiting

Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer